Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE DM)
Conditions:   Diabetes Mellitus;   Pre Diabetes;   ASCVD Interventions:   Drug: high-intensity statin arm;   Drug: low-intensity statin plus ezetimibe Sponsors:   CardioVascular Research Foundation, Korea;   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials